A potential role for apoptosis in neurodegeneration and Alzheimer's disease

Molecular Neurobiology

Volumn 10, Issue 1, 1995, Pages 19-45

  Cotman, Carl W ^a   Anderson, Aileen J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c fos, plaques; c jun; DNA fragmentation; immediate early gene; neurofibrillary tangles; oxidative injury; Programmed cell death; proto oncogene

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; APOPTOSIS; BRAIN; HUMAN; NECROSIS; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMAL; APOPTOSIS; BRAIN; HUMAN; NECROSIS; NERVE DEGENERATION; NEURONS;

EID: 0029245289     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/BF02740836     Document Type: Article

References (215)

1. Expression and purification of the leucine zipper and DNA binding domains of Fos and Jun: both Fos and Jun contact DNA directly
2. Redox regulation of fos and jun DNA-binding activity in vitro
3. Activation of internucleosomal DNA cleavage in human CEM lymphocytes by glucocorticoid and novobiocin. Evidence for a non-Ca2(+)-requiring mechanism(s)
4. Oxidants, antioxidants, and the degenerative diseases of aging
5. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology
6. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1
7. Apoptosis: mechanisms and roles in pathology
8. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum
9. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1–40)] in bilayer membranes
10. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes
11. Dexamethasone-induced killing of neoplastic cells of lymphoid derivation: lack of early calcium involvement
12. Aurintri-carboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity
13. Do deficits in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
14. Vitamin E protects nerve cells from amyloid beta protein toxicity
15. Amyloid beta peptide induces necrosis rather than apoptosis
16. Hydrogen peroxide mediates amyloid beta protein toxicity
17. Granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells
18. Apoptotic cell death induced by c-myc is inhibited by Bcl-2
19. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
20. Identification of NF-jun, a novel inducible transcription factor that regulates c-jun gene transcription
21. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells
22. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
23. Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate
24. Cell death by apoptosis and its protective role against disease
25. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells
26. Methodological variables in the assessment of beta amyloid neurotoxicity
27. Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland
28. Earlyonset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene
29. Characterization of apoptosis induced by transforming growth factor beta 1 in human hepatoma cells
30. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease
31. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines
32. β-amyloid increases neuronal susceptibility to injury by glucose deprivation
33. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families (see comments)
34. Retention of function in the aged brain: the pivotal role of Aβ
35. The role of misdirected plasticity in plaque biogenesis and Alzheimer's disease pathology
36. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle
37. Neuritic involvement within bFGF immunopositive plaques in Alzheimer's disease
38. b-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease
39. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor
40. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106–126 of the prion protein
41. Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: evidence against programmed cell death
42. Anisomycin and cycloheximide protect cerebellar neurons in culture from anoxia
43. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes
44. Bilateral injections of βA(25–35)+IBO into the hippocampus disrupts acquisition of spatial learning in the rat
45. Immediate-early gene proteins expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain
46. Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury?
47. Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis
48. Mechanisms and functions of cell death
49. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain
50. Apoptotic cell death occurs in hippocampal neurons cultured in a high oxygen atmosphere
51. Induction of apoptosis in fibroblasts by c-myc protein
52. Neurotoxicity of a prion protein fragment
53. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25–35
54. Systemic and cerebral amyloidosis
55. Alzheimer Aβ amyloid forms an inhibitory neuronal substrate
56. Effects of injected Alzheimer beta-amyloid cores in rat brain
57. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death
58. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene
59. Alzheimer's disease: initial report of the purification of a novel cerebrovascular amyloid protein
60. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease (see comments)
61. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease
62. Prolonged expression of c-jun and associated activity of the transcription factor AP-1, during apoptosis in a human leukaemic cell line
63. Positron emission tomographic (PET) studies in dementia
64. Effects of cycloheximide on delayed neuronal death in rat hippocampus
65. Chemical characterization of Aβ 17–42 peptide, a component of diffuse amyloid deposits of Alzheimer's disease
66. Studies of the relationship between cell proliferation and cell death II. Early gene expression during concanavalin A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes
67. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine
68. Amyloid β-peptide is produced by cultured cells during normal metabolism
69. Oxidants and the central nervous system: some fundamental questions
70. Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment
71. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease
72. Mediation of c-Myc-induced apoptosis by p53
73. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain
74. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
75. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
76. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?
77. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation
78. A “calcium set-point hypothesis” of neuronal dependence on neurotrophic factor
79. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
80. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
81. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
82. Definition and incidence of apoptosis: an historical perspective
83. Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells
84. Are the neuroprotective effects of the protein synthesis inhibitor cycloheximide due to prevention of apoptosis?
85. Activation of a suicide process of thymocytes through DNA fragmentation by calcium ionophores and phorbol esters
86. Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines
87. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase afflux assay
88. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
89. Role of Ca++ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: evidence that levels of internal Ca++ determine nerve growth factor dependence of sympathetic ganglion cells
90. In vivo neurotoxocity of beta-amyloid [beta(1–40)] and the beta(25–35) fragment
91. Apoptosis of murine BW 5147 thymoma cells induced by cold shock
92. Mathyelmercury induces apoptosis of rat cerebellar neurons in primary culture
93. Glutamate triggers internucleosomal DNA cleavage in neuronal cells
94. Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukemia cells
95. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
96. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur 77
97. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons
98. Pancreatic islet cell toxicity to amylin associated with type-2 diabetes mellitus
99. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease
100. N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells
101. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of the Alzheimer's type and Down's syndrome in middle age
102. Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease
103. Early response gene induction following DNA damage in astrocytoma cell lines
104. Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation
105. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells
106. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation
107. Dicing with death: dissecting the components of the apoptosis machinery
108. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis
109. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels
110. Amyloid plaque core protein in Alzheimer disease and Down syndrome
111. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
112. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF
113. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
114. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-β neurotoxicity
115. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease
116. Calcium-dependent cell death. Role of the endonuclease, protein kinase C, and chromatin conformation
117. 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation
118. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C
119. Calcium-activated DNA fragmentation kills immature thymocytes
120. Glucocorticoids activate a suicide process in thymo cytes through an elevation of cytosolic calcium concentration
121. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes
122. Cellular signaling in thymocyte apoptosis
123. Cyclic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes
124. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease
125. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
126. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
127. Apoptosis—programmed cell death: a role in the aging process?
128. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun
129. Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia
130. Cortical neuronal counts in normal elderly controls and demented patients
131. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene
132. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
133. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
134. Apolipoprotein E immuno-reactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
135. Linkage of familial Alzheimer disease to chromosome 14 in two large early-onset pedigrees: effects of marker allele frequencies on lod scores
136. Genetics and biology of the Alzheimer amyloid precursor
137. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
138. Effect of transforming growth factor beta on cell death of cultured rat hepatocytes
139. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β1
140. Protein kinase-C involvement in thymocyte apoptosis induced by hydrocortisone
141. A radical hypothesis for neuro-degeneration
142. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
143. Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes
144. Role of Ca++ in toxic cell killing
145. Identification of mRNAs associated with programmed cell death in immature thymocytes
146. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease
147. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly site
148. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid
149. β-amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology
150. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
151. Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures
152. A system for characterizing cellular and molecular events in programmed neuronal cell death
153. Apoptosis associated DNA fragmentation in epileptic brain damage
154. Differences between vascular and plaque core amyloid in Alzheimer's disease
155. Expression of the baculovirus p35 gene inhibits mammalian neural cell death
156. Programmed cell death and the control of cell survival: lessons from the nervous system
157. Oxidative stress induces apoptosis in embryonic cortical neurons
158. Fos and Jun bind cooperatively to the AP-1 site: reconstruction in vitro
159. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions
160. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides
161. A postmortem study of the cholinergic and GABA systems in senile dementia
162. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide
163. cis-diamminedichloroplatinum (II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway
164. Hyperactivation of signal transduction systems in Alzheimer's disease
165. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
166. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
167. Chromosome 14 and late-onset familial Alzheimer disease (FAD)
168. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
169. Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus
170. Inhibition of protein synthesis prevents cell death in sensory and parasympathetic neurons deprived of neurotrophic factor in vitro
171. Isolation of low molecular weight proteins from amyloid plaque fibers in Alzheimer's disease
172. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106–126 of the prion protein
173. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
174. The regulation and function of c- fos and other immediate early genes in the nervous system
175. Role for c-myc in activation-induced apoptotic cell death in T-cell hybridomas
176. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor
177. Reduction of delayed neuronal death by inhibition of protein synthesis
178. Production of the Alzheimer Amyloid β protein by normal proteolytic processing
179. Studies of the relationship between cell proliferation and cell death. III. AP-I DNA-binding activity during concanavalin A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes
180. Transcription factors DNA-binding activity in rat thymocytes undergoing apoptosis after heat-shock or dexamethasone treatment
181. Continuous c-fos expression precedes programmed cell death in vivo
182. Multiple gene regulation of apoptosis: significance in immunology and oncology
183. Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease
184. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer’s disease
185. Regulation of proenkephalin by Fos and Jun
186. Selective vulnerability of neurones in organic dementia
187. Genetic evidence for a novel familial Alzheimer’s disease locus on chromosome 14
188. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
189. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease
190. Evidence for DNA fragmentation in neurons in the AD brain
191. Synthetic peptides homologous to prion protein residues 106–147 form amyloid-like fibrils in vitro
192. Toxic effect of a beta-amyloid peptide (beta 22–35) on the hippocampal neuron and its prevention
193. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus
194. Some morphometric aspects of the brain in senile dementia of the Alzheimer type
195. Focal ischemia in rats causes time-dependent expression of c-Fos protein immuno-reactivity in widespread regions of ipsilateral cortex
196. Mapping of a gene predisposing to early-onset Alzheimer’s disease to chromosome 14q24.3
197. Characterization of beta-amyloid peptide from human cerebrospinal fluid
198. Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation, and AP1
199. DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels
200. Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons
201. Amyloid beta protein enhances the survival of hippocampal neurons in vitro
202. Hydrogen peroxide induces apoptosis in cultured neurons
203. Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro
204. Alzheimer’s disease and soluble Ab
205. Apolipoprotein E: binding to soluble Alzheimer’s beta-amyloid
206. Cell death: the significance of apoptosis
207. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis
208. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease
209. Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides
210. p53-mediated cell death: relationship to cell cycle control
211. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
212. Delayed internucleosomal DNA fragmentation in programmed cell death
213. c-Fos protein-like immuno-reactivity: distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer’s disease
214. bcl-2 inhibits death of central neural cells induced by multiple agents